"The Jewish Hospital - Mercy Health provides award-winning, compassionate health care to people of every faith, and includes Greater Cincinnati's only adult blood and marrow transplant center."

During the past decade, The Jewish Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 24 clinical trials were completed, i.e. on average, 342.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Jewish Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "NSABP Foundation Inc" with 6 trials sponsored, "Jewish Hospital, Cincinnati, Ohio" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "University of Cincinnati" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Jewish Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "Medical University of South Carolina" with 2 trials as a collaborator, "University of Pittsburgh" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "The Jewish Hospital" are "Stroke" (7 trials), "Breast Cancer" (6 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Acute Myeloid Leukemia" (3 trials) and "Adult Acute Megakaryoblastic Leukemia (M7)" (2 trials). Many other conditions were trialed in "The Jewish Hospital" in a lesser frequency.

Most popular intervention types in "The Jewish Hospital" are "Drug" (38 trials), "Other" (12 trials), "Procedure" (10 trials), "Biological" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "Cytarabine" (5 trials), "Placebo" (5 trials), "Laboratory Biomarker Analysis" (4 trials) and "Allogeneic Hematopoietic Stem Cell Transplantation" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Jewish Hospital" are 42 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "The Jewish Hospital". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in The Jewish Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in The Jewish Hospital, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

The Jewish Hospital has several departments that took part in Clinical trials: "Jewish Hospital BMT Program" - 12 trials